Soltan Dallal Mm, Nikkhahi F, Khirkhah A, Molaei S, Hosseyni Sk, Rastegar Lari A, Rahimi Foroushani A, Khoshzaban A, Kalafi Z,
Volume 69, Issue 10 (1-2012)
Abstract
Normal
0
false
false
false
EN-US
X-NONE
AR-SA
MicrosoftInternetExplorer4
Background: Human
amniotic membrane (HAM) forms the inner wall of the membranous sac that surrounds and
protects the embryo during gestation.
The main advantages of amniotic membrane transplantation (AMT) in the treatment of bacterial
keratitis are its epithelial bandage properties. Previous studies have
documented the presence of some antimicrobial proteins and peptides in amniotic
fluid such as lactoferrin, lysozyme, bactericidal or permeability increasing
protein, calprotectin (MRP8/14 protein complex), LL37, and neutrophil defensins (Human Neutrophil Peptides, HNP
1-3). Furthermore, the amniotic membrane does
not express HLA-A, B, C or DR surface antigens, which may help avoid rejection after its transplantation.
Thus, it can be used as a biological immune barrier. The purpose of this study was
to evaluate the effectiveness of the amniotic membrane's healing properties in
rabbits with pseudomonas keratitis.
Methods : By using an animal model, 14 rabbits were divided into two groups of controls and cases. A syringe was used to inoculate
the corneal stroma of the animals by Pseudomonas aeruginosa ATCC27853. After 20 hours
pseudomonas keratitis was created and amniotic membrane was transplanted to the
cornea of the case group. The infiltration size were observed on the first, third
and seventh days after the experiment.
Results : Corneal perforation was seen in the controls (P<0.001) but amniotic membrane
prevented perforation in the case group (P=0.02).
Conclusion: Transplantation of
amniotic membrane in the primary stages of pseudomonas keratitis treatment remarkably
prevents corneal perforation and it can be used to control the disease process.